AR and posterior cortical atrophy: In addition, ellagitannin inhibited the expression of androgen receptor (AR) and androgen synthesizing enzymes, such as 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) and steroid 5α reductase type I (SRD5A1), in PCa cells [24].